Erlotinib Completed Phase 2 Trials for Adenocarcinoma of the Pancreas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01389440Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer